BR112018009396A2 - composição bacteriana para uso em atenuar o declínio de desempenho após exercício - Google Patents

composição bacteriana para uso em atenuar o declínio de desempenho após exercício

Info

Publication number
BR112018009396A2
BR112018009396A2 BR112018009396-3A BR112018009396A BR112018009396A2 BR 112018009396 A2 BR112018009396 A2 BR 112018009396A2 BR 112018009396 A BR112018009396 A BR 112018009396A BR 112018009396 A2 BR112018009396 A2 BR 112018009396A2
Authority
BR
Brazil
Prior art keywords
exercise
bacterial composition
performance decline
mitigating performance
mitigating
Prior art date
Application number
BR112018009396-3A
Other languages
English (en)
Other versions
BR112018009396A8 (pt
BR112018009396B1 (pt
Inventor
Mogna Giovanni
Original Assignee
Probiotical S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical S.P.A. filed Critical Probiotical S.P.A.
Publication of BR112018009396A2 publication Critical patent/BR112018009396A2/pt
Publication of BR112018009396A8 publication Critical patent/BR112018009396A8/pt
Publication of BR112018009396B1 publication Critical patent/BR112018009396B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção refere-se a uma composição bacteriana que pode ser efetivamente usada no campo da nutrição esportiva, uma vez que é capaz de atenuar o declínio no desempenho esportivo em um indivíduo após um exercício com lesão muscular.
BR112018009396-3A 2015-11-19 2016-11-17 Uso não terapêutico de uma mistura de bactérias e composição compreendendo as mesmas BR112018009396B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUB2015A005752A ITUB20155752A1 (it) 2015-11-19 2015-11-19 Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
IT102015000074653 2015-11-19
PCT/IB2016/056919 WO2017085656A1 (en) 2015-11-19 2016-11-17 Bacterial composition for use in attenuating the decline in performance after exercise

Publications (3)

Publication Number Publication Date
BR112018009396A2 true BR112018009396A2 (pt) 2018-11-13
BR112018009396A8 BR112018009396A8 (pt) 2019-02-26
BR112018009396B1 BR112018009396B1 (pt) 2021-12-07

Family

ID=55447032

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018009396-3A BR112018009396B1 (pt) 2015-11-19 2016-11-17 Uso não terapêutico de uma mistura de bactérias e composição compreendendo as mesmas

Country Status (12)

Country Link
US (1) US11191792B2 (pt)
EP (1) EP3377081A1 (pt)
JP (1) JP6965259B2 (pt)
KR (1) KR20180094511A (pt)
CN (1) CN108430484A (pt)
AU (1) AU2016356324B2 (pt)
BR (1) BR112018009396B1 (pt)
CA (1) CA3004486A1 (pt)
HK (1) HK1254884A1 (pt)
IT (1) ITUB20155752A1 (pt)
RU (1) RU2722270C2 (pt)
WO (1) WO2017085656A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3704958A4 (en) * 2017-10-31 2021-06-30 Morinaga Milk Industry Co., Ltd. COMPOSITION FOR INCREASING MUSCLE MASS
KR20210017737A (ko) 2019-08-09 2021-02-17 조유진 낯선사람을 감지해 녹화기능을 수행하는 도어락
KR20230074217A (ko) * 2020-09-23 2023-05-26 유키지루시 메그밀크 가부시키가이샤 근위축 예방제
CN117503804A (zh) 2022-07-29 2024-02-06 生展生物科技股份有限公司 嗜热链球菌st7发酵物组合物用于提升运动表现及减缓肌少症的用途
CN117551587A (zh) * 2023-12-22 2024-02-13 北京科拓恒通生物技术股份有限公司 一种促进运动后恢复或增强运动能力的两歧双歧杆菌bf-01和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
AU2015100928A4 (en) * 2014-05-21 2015-10-15 Medlab Ip Pty Ltd Probiotic combinations and uses thereof
CN104996992A (zh) * 2015-04-10 2015-10-28 劲膳美生物科技股份有限公司 肌肉衰减综合征医学配方食品

Also Published As

Publication number Publication date
ITUB20155752A1 (it) 2017-05-19
US11191792B2 (en) 2021-12-07
CA3004486A1 (en) 2017-05-26
BR112018009396A8 (pt) 2019-02-26
EP3377081A1 (en) 2018-09-26
JP2018538369A (ja) 2018-12-27
RU2018121974A (ru) 2019-12-19
AU2016356324B2 (en) 2023-08-10
RU2722270C2 (ru) 2020-05-28
BR112018009396B1 (pt) 2021-12-07
AU2016356324A1 (en) 2018-05-17
WO2017085656A1 (en) 2017-05-26
JP6965259B2 (ja) 2021-11-10
KR20180094511A (ko) 2018-08-23
US20180318363A1 (en) 2018-11-08
HK1254884A1 (zh) 2019-07-26
CN108430484A (zh) 2018-08-21
RU2018121974A3 (pt) 2019-12-19

Similar Documents

Publication Publication Date Title
BR112018009396A8 (pt) composição bacteriana para uso em atenuar o declínio de desempenho após exercício
CO2017005626A2 (es) Una composición que comprende bacteroides thetaiotaomicron
SG11202004585UA (en) Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the r-enantiomer and methods of use
DOP2019000005A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
CL2018003588A1 (es) Uso de inhibidores de miostatina y terapias de combinación.
SG11202005546UA (en) Non-racemic beta-hydroxybutyrate compounds and compositions enriched with s-enantiomer and methods of use
ECSP19043725A (es) Composiciones de aminoácidos y métodos para el tratamiento de enfermedades y trastornos musculares
BR112016017690A2 (pt) Tratamentos para acne resistente
BR112016024319A2 (pt) métodos para aumentar os níveis de hemácias e tratar anemia falciforme
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
TWD182555S (zh) 運動器材之部分
BR112016020618A8 (pt) oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido
CL2015002677A1 (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial.
BR112016021034A8 (pt) composição farmacêutica, uso da mesma e kit
BR112016028845A2 (pt) composto, composição farmacêutica e uso de um composto
BR112018007958A2 (pt) composições e métodos que usam um polifenol para a saúde musculoesquelética
BR112018006368A2 (pt) composição para desempenho melhorado
BR112015029987A8 (pt) Beta-caseína a2 e a prevenção de inflamação do intestino
BR112012022727A2 (pt) uso de um ou mais agentes quelantes, composição nutricional, e métodos para prover nutricição a uma pessoa em necessidade da mesma
MX2023010501A (es) Profarmacos de dantroleno y metodos de su uso.
BR112017022158A2 (pt) compostos, composições farmacêuticas e uso de um composto
CO2017007874A2 (es) Composiciones y métodos para metabolismo muscular mejorado
MX2016015092A (es) Inhibidor de proliferacion de celulas madre cancerosas.
BR112017013770A2 (pt) composições de inibidor de nitrificação microencapsuladas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/11/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 7A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2749 DE 12-09-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.